Cocrystal Pharma, Inc. — Investor Relations & Filings
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company that discovers and develops novel antiviral therapeutics for serious and chronic viral diseases. The company utilizes proprietary structure-based drug design technologies to create antiviral drugs that target the viral replication process. Its development pipeline includes programs targeting influenza, SARS-CoV-2 (COVID-19), norovirus, and hepatitis C. Key candidates in its pipeline include CC-42344, a PB2 inhibitor for influenza A in Phase 2 clinical trials, and CDI-988, an oral pan-viral protease inhibitor for norovirus and coronaviruses that has entered Phase 1 trials.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K Filing | 2025-10-30 | English | |
| 4 Filing | 2025-10-30 | English | |
| 8-K Filing | 2025-10-27 | English | |
| SCHEDULE 13D/A Filing | 2025-10-02 | English | |
| 424B3 Filing | 2025-09-29 | English | |
| S-1 Filing | 2025-09-19 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 29570768 | 8-K Filing | 2025-10-30 | English | ||
| 29570749 | 4 Filing | 2025-10-30 | English | ||
| 29572327 | 8-K Filing | 2025-10-27 | English | ||
| 29570732 | SCHEDULE 13D/A Filing | 2025-10-02 | English | ||
| 29572656 | 424B3 Filing | 2025-09-29 | English | ||
| 29572816 | S-1 Filing | 2025-09-19 | English | ||
| 29572961 | 424B5 Filing | 2025-09-15 | English | ||
| 29572769 | 8-K Filing | 2025-09-15 | English | ||
| 29572666 | 8-K Filing | 2025-09-12 | English | ||
| 29572658 | 8-K Filing | 2025-09-12 | English | ||
| 29572333 | 424B3 Filing | 2025-09-12 | English | ||
| 29572750 | 10-Q Filing | 2025-08-14 | English | ||
| 29570769 | 8-K Filing | 2025-08-14 | English | ||
| 29572706 | 8-K Filing | 2025-08-05 | English | ||
| 29572825 | 8-K Filing | 2025-07-10 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Cocrystal Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35066/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35066 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35066 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35066 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35066}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cocrystal Pharma, Inc. (id: 35066)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.